Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA) (CORIA)
Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA): a Multisite Registry and Optional Biorepository in People With COVID-19 and Selected Conditions Affecting Immune Function
Sponsor: Blacktown Hospital, Sydney, Australia
This observational or N/A phase trial investigates COVID-19 and Cancer and is currently ongoing. Blacktown Hospital, Sydney, Australia leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Sep 2023 — Jul 2024 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Oct 2021 — Sep 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2020 — Jul 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Blacktown Hospital, Sydney, Australia
- Cancer Council New South Wales
- Cancer Institute NSW
- Garvan Institute of Medical Research
- Gilead Sciences
- Holdsworth House Medical Practice
- Kirby Institute
- Liverpool Hospital, Sydney
- Melanoma Institute Australia
- Positive Life NSW
- Prince of Wales Hospital, Sydney
- Royal North Shore Hospital
- St George Hospital, Australia
- St Vincent's Hospital, Sydney
- Westmead Hospital, Sydney, Australia
For direct contact, visit the study record on ClinicalTrials.gov .